Michael Thurn

Michael Thurn

Direttore/Membro del Consiglio presso NEURIZON THERAPEUTICS LIMITED

Patrimonio netto: 127 998 $ in data 31/05/2026

Health Technology
Consumer Services
Health Services

Profilo

Michael Thurn is the founder of Marp Therapeutics Pty Ltd. Current positions include Non-Executive Director at Arovella Therapeutics Ltd. starting in 2026, Director at Inmagene Biopharmaceuticals, Director at Impel Neuropharma, and Non-Executive Director at Neurizon Therapeutics Ltd. starting in 2026.
Former roles include Chief Executive Officer at Mimetica Pty Ltd. from 2006 to 2014, Chief Executive Officer at Neurizon Therapeutics Ltd. from 2023 to 2024, Chief Operating Officer & Executive Director at Botanix Pharmaceuticals Ltd. from 2019 to 2020, Managing Director at Spinifex Pharmaceuticals Pty Ltd., Director at Erasca, Inc., Team Leader at Kazia Therapeutics Ltd., Chief Operating Officer at YM BioSciences Australia Pty Ltd., Head-Drug Development at Xenome Ltd., and Senior Toxicologist at Therapeutic Goods Administration.
Education includes a doctorate from the University of Technology Sydney conferred in 1994.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
07/11/2024 2.869.276 ( 0,38% ) 127 998 $ 31/05/2026

Posizioni attive di Michael Thurn

SocietàPosizioneInizio
NEURIZON THERAPEUTICS LIMITED Direttore/Membro del Consiglio 31/05/2024
AROVELLA THERAPEUTICS LIMITED Direttore/Membro del Consiglio 28/04/2026

Precedenti posizioni note di Michael Thurn

SocietàPosizioneFine
NEURIZON THERAPEUTICS LIMITED Amministratore Delegato 23/04/2024
BOTANIX PHARMACEUTICALS LIMITED Direttore operativo 26/02/2020
ERASCA, INC. Direttore/Membro del Consiglio -
Fondatore -
Therapeutic Goods Administration
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Michael Thurn

Formazione di Michael Thurn

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

36

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Therapeutic Goods Administration

Health Technology

Health Services

  1. Mercati
  2. Insiders
  3. Michael Thurn
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA